Mostrando 581 - 600 Resultados de 84,353 Para Buscar '"HR"', tiempo de consulta: 0.56s Limitar resultados
  1. 581
  2. 582
  3. 583
    por CERN. Geneva
    Publicado 2019
    Materias: “…HR Public Meetings…”
    Enlace del recurso
  4. 584
    por Purvis, James
    Publicado 2019
    Materias: “…HR Public Meetings…”
    Enlace del recurso
  5. 585
  6. 586
  7. 587
  8. 588
    “…We hereby establish the role of elevated lamin A in neoplastic transformation in the context of high-grade ovarian serous cancer through a combination of HR and NHEJ mechanisms.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 589
  10. 590
    “…Here, we show that a post-mitotic binary fate decision in Drosophila color photoreceptor subtype specification requires ecdysone signaling and involves orthologs of these transcription factors: Drosophila Blimp-1/PRDM1 and Hr3/RORβ promote blue-sensitive (Rh5) photoreceptor fate and repress green-sensitive (Rh6) photoreceptor fate through the transcriptional repression of warts/LATS, the nexus of the phylogenetically conserved Hippo tumor suppressor pathway. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 591
  12. 592
    “…Our study shows the significant tumor cell expression of TIM-3 in specific subsets of patients with high risk soft tissue sarcomas (HR-STS). We demonstrate an interaction between TIM-3, tumor infiltrating lymphocyte (TIL) counts and PD-1/PD-L1 expression in patients with HR-STS. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 593
  14. 594
    “…Peripheral bone microarchitecture at the distal radius and tibia were evaluated by high-resolution peripheral quantitative computed tomography (HR-pQCT). Biochemical markers of PGE2, bone turnover, and Dickkopf-1 (DKK1) were investigated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 595
  16. 596
    “…INTRODUCTION/OBJECTIVES: To describe abemaciclib use in patients with hormone receptor-positive, human epidermal growth factor receptor-negative (HR+/HER2−) metastatic breast cancer (mBC) who participated in the Named Patient Use program (NPU) in Spain. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 597
  18. 598
  19. 599
    Publicado 1995
    “…A monoclonal antibody raised to Ov39 also reacted with hr44 and gave evidence for a shared conformational epitope. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  20. 600
Herramientas de búsqueda: RSS